Francine Lane is Vice President of Global Transparency at TrialScope, the global leader in clinical trial transparency, disclosure compliance and patient engagement solutions. While her official title is VP, she is also serves as product director.
In this capacity, she oversees upgrades to existing solutions and the development of new technologies for TrialScope Disclose™, the central component of the TrialScope Transparency Cloud™. The trial disclosure management solution is used by 16 of the top 20 pharmaceutical companies.
Francine guided the launch of TrialScope Engage™. This platform enables clinical trial sponsors to engage with patients, healthcare professionals, researchers and the public via clinical trial websites automatically updated with trial data submitted to regulatory agencies. It was named one of the most innovative services of 2018 in life sciences.
Francine also serves as Chair of the Drug Information Association Clinical Trial Disclosure Community.
